Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer

Lu, YL; Wu, MH; Lee, YY; Chou, TC; Wong, RCJ; Lin, SF

Lin, SF (corresponding author), New Taipei Municipal TuCheng Hosp, Dept Internal Med, Chang Gung Med Fdn, New Taipei 23652, Taiwan.; Lin, SF (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Taoyuan 33305, Taiwan.; Lin, SF (corresponding author), Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan.

CANCERS, 2021; 13 (14):

Abstract

Simple Summary Adavosertib is a first-in-class Wee1 inhibitor that has demonstrated activity against certain cancers. We evaluated the effects of adav......

Full Text Link